The Anti-ITGA4 (Natalizumab Biosimilar) Antibody (HDBS0068) is a vital tool for research involving integrin alpha-4 (ITGA4), a cell surface protein involved in cell adhesion and migration processes. This antibody, produced through a biosimilar to Natalizumab, is highly specific and reactive with human samples, making it suitable for various applications such as immunohistochemistry, flow cytometry, and ELISA.ITGA4 is a key player in the immune system, mediating the adhesion of immune cells to the endothelium during inflammation and immune surveillance. Dysregulation of ITGA4 function has been linked to autoimmune diseases, inflammatory disorders, and cancer progression.
By targeting ITGA4 with the Anti-ITGA4 Antibody, researchers can further investigate the role of this protein in disease pathogenesis and potentially identify novel therapeutic strategies to modulate immune responses.In summary, the Anti-ITGA4 (Natalizumab Biosimilar) Antibody (HDBS0068) is a valuable research tool for studying ITGA4-mediated processes in immunology, inflammation, and cancer biology. Its high specificity and reactivity with human samples make it a reliable choice for researchers seeking to elucidate the role of ITGA4 in health and disease.
Product Name:
Natalizumab (Anti-ITGA4) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0068
Target:
ITGA4
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
AN100226,AN100226,BG00002
Description:
Anti-ITGA4?natalizumab biosimilar? mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.